This book examines how government, industry and society interact to reach a level of regulation that is deemed satisfactory for the newly-emerged transformative technology that is agricultural biotechnology. It considers issues of risk and trust surrounding genetically modified plants for the production of food and pharmaceuticals. It describes how regulations have been produced to manage, or in some cases ignore, the risks from GM products. The scope is international and the book makes a significant contribution to the literature in this growing field of interest.
show more
show less
| |
| |
| |
| Liability and transformative technology | |
| |
| |
| |
| Innovation and liability | |
| |
| |
| |
| Social amplification of risk | |
| |
| |
| |
| Consumer responses to GM foods | |
| |
| |
| |
| Regulating transformative technologies | |
| |
| |
| |
| International governance of liabilities | |
| |
| |
| |
| Biological mechanisms to control GM liabilities | |
| |
| |
| |
| Supply chain responses to liability | |
| |
| |
| |
| Product differentiation strategies | |
| |
| |
| |
| Liability of plant-made pharmaceuticals | |
| |
| |
| |
| Handling liabilities from transformative technologies | |
Peter W.B. Phillips is a professor in the Department of Political Studies at the University of Saskatchewan.